RecruitingNot ApplicableNCT06431269

Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease

Sponsor

University Hospital, Montpellier

Enrollment

270 participants

Start Date

May 31, 2024

Study Type

INTERVENTIONAL

Conditions

Neurodevelopmental Disorders Congenital Heart Disease in Children

Summary

Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease

Eligibility

Min Age: 1 YearMax Age: 5 Years

Inclusion Criteria6

Congenital heart disease with stable status defined by last operation >3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion
Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
Patient aged 1 to 5 years.
No previous medical diagnosis of NDD
Parental or legal guardian's consent.
Social security affiliation (for France only)

Exclusion Criteria3

Patients with a genetic or poly-malformative syndrome with known neurological impairment.
Neurodevelopmental disorder already known/treated
Neurodevelopmental status evaluation within the last 6 months.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERScreening for neurodevelopmental disorders by an advanced practice nurse

Screening for neurodevelopmental disorders by an advanced practice nurse with Ages \& Stages Questionnaires (ASQ-3) and Haute Autorité de Santé (HAS) identification scale

Locations(3)

University Hospitial of Montpellier

Montpellier, France

Institut Marin Saint-Pierre

Palavas-les-Flots, France

CHU Bordeaux Haut-Lévêque

Pessac, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06431269

Related Trials

Motor-voice Assessment in Infants (MAMI)

NCT068072031 location

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

NCT074930961 location